PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio.

Abstract Eliminating the risk of polio from vaccine-derived polioviruses is essential for creating a polio-free world, and eliminating that risk will require stopping use of all oral polio vaccines (OPVs) once all types of wild polioviruses have been eradicated. In many ways, the experience with the global switch from trivalent OPV (tOPV) to bivalent OPV (bOPV) can inform the eventual full global withdrawal of OPV. Significant preparation will be needed for a thorough, synchronized, and full withdrawal of OPV, and such preparation would be aided by setting a reasonably firm date for OPV withdrawal as far in advance as possible, ideally at least 24 months. A shorter lead time would provide valuable flexibility for decisions about when to stop use of OPV in the context of uncertainty about whether or not all types of wild polioviruses had been eradicated, but it might increase the cost of OPV withdrawal.
PMID
Related Publications

Polio endgame: the global switch from tOPV to bOPV.

Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.

Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.

Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.

Authors

Mayor MeshTerms

Disease Eradication

Global Health

Poliomyelitis

Poliovirus Vaccine, Oral

Keywords

Oral polio vaccine

polio eradication

vaccine derived polioviruses

Journal Title the journal of infectious diseases
Publication Year Start




PMID- 28838193
OWN - NLM
STAT- MEDLINE
DA  - 20170825
DCOM- 20170905
LR  - 20170906
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 216
IP  - suppl_1
DP  - 2017 Jul 01
TI  - Considerations for the Full Global Withdrawal of Oral Polio Vaccine After
      Eradication of Polio.
PG  - S217-S225
LID - 10.1093/infdis/jix105 [doi]
AB  - Eliminating the risk of polio from vaccine-derived polioviruses is essential for 
      creating a polio-free world, and eliminating that risk will require stopping use 
      of all oral polio vaccines (OPVs) once all types of wild polioviruses have been
      eradicated. In many ways, the experience with the global switch from trivalent
      OPV (tOPV) to bivalent OPV (bOPV) can inform the eventual full global withdrawal 
      of OPV. Significant preparation will be needed for a thorough, synchronized, and 
      full withdrawal of OPV, and such preparation would be aided by setting a
      reasonably firm date for OPV withdrawal as far in advance as possible, ideally at
      least 24 months. A shorter lead time would provide valuable flexibility for
      decisions about when to stop use of OPV in the context of uncertainty about
      whether or not all types of wild polioviruses had been eradicated, but it might
      increase the cost of OPV withdrawal.
CI  - (c) The Author 2017. Published by Oxford University Press for the Infectious
      Diseases Society of America.
FAU - Hampton, Lee M
AU  - Hampton LM
AD  - Global Immunization Division, Centers for Disease Control and Prevention,
      Atlanta, Georgia.
FAU - du Chatellier, Gael Maufras
AU  - du Chatellier GM
AD  - West and Central Africa Regional Office, UNICEF, Dakar, Senegal.
FAU - Fournier-Caruana, Jacqueline
AU  - Fournier-Caruana J
AD  - World Health Organization, Geneva, Switzerland.
FAU - Ottosen, Ann
AU  - Ottosen A
AD  - Supply Division, UNICEF, Copenhagen, Denmark.
FAU - Rubin, Jennifer
AU  - Rubin J
AD  - Supply Division, UNICEF, Copenhagen, Denmark.
FAU - Menning, Lisa
AU  - Menning L
AD  - World Health Organization, Geneva, Switzerland.
FAU - Farrell, Margaret
AU  - Farrell M
AD  - Program Division, United Nations Children's Fund (UNICEF), New York, New York.
FAU - Shendale, Stephanie
AU  - Shendale S
AD  - World Health Organization, Geneva, Switzerland.
FAU - Patel, Manish
AU  - Patel M
AD  - Task Force for Global Health, Atlanta, Georgia.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
RN  - 0 (Poliovirus Vaccine, Oral)
SB  - AIM
SB  - IM
MH  - *Disease Eradication
MH  - Disease Outbreaks/*prevention & control
MH  - *Global Health
MH  - Humans
MH  - *Poliomyelitis/prevention & control/transmission/virology
MH  - *Poliovirus Vaccine, Oral
OTO - NOTNLM
OT  - Oral polio vaccine
OT  - polio eradication
OT  - vaccine derived polioviruses
EDAT- 2017/08/26 06:00
MHDA- 2017/09/07 06:00
CRDT- 2017/08/26 06:00
AID - 3935071 [pii]
AID - 10.1093/infdis/jix105 [doi]
PST - ppublish
SO  - J Infect Dis. 2017 Jul 1;216(suppl_1):S217-S225. doi: 10.1093/infdis/jix105.